Fanglong Yang

490 total citations
18 papers, 218 citations indexed

About

Fanglong Yang is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fanglong Yang has authored 18 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fanglong Yang's work include Pharmacological Receptor Mechanisms and Effects (3 papers), Microtubule and mitosis dynamics (3 papers) and Chemical Synthesis and Analysis (2 papers). Fanglong Yang is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (3 papers), Microtubule and mitosis dynamics (3 papers) and Chemical Synthesis and Analysis (2 papers). Fanglong Yang collaborates with scholars based in China and United States. Fanglong Yang's co-authors include Dennis P. Curran, Yu Ding, Gang Zhao, Zongbao K. Zhao, Yue‐Qing Zheng, Billy W. Day, Guangyu Zhu, Raghavan Balachandran, Peter Höök and Richard B. Vallee and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Fanglong Yang

15 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fanglong Yang China	9	133	79	24	20	14	18	218
Pál Tapolcsányi Hungary	12	407 3.1×	198 2.5×	34 1.4×	8 0.4×	10 0.7×	25	526
Clint A. James Canada	9	252 1.9×	80 1.0×	40 1.7×	6 0.3×	7 0.5×	12	321
Ahmed Abouabdellah France	12	259 1.9×	102 1.3×	71 3.0×	5 0.3×	4 0.3×	19	368
Antonio Pillan Italy	9	111 0.8×	73 0.9×	49 2.0×	10 0.5×	2 0.1×	14	176
Jason K. Dutra United States	8	168 1.3×	86 1.1×	40 1.7×	17 0.8×		14	275
Steven P. Govek United States	8	297 2.2×	104 1.3×	43 1.8×	5 0.3×	23 1.6×	10	384
Rune Risgaard Denmark	7	225 1.7×	162 2.1×	23 1.0×	2 0.1×	31 2.2×	9	391
Jonathan L. Ditta United States	10	232 1.7×	144 1.8×	24 1.0×	6 0.3×	5 0.4×	12	338
Tomasz M. Wróbel Poland	11	75 0.6×	154 1.9×	22 0.9×	6 0.3×	1 0.1×	40	304
Timothy N. Birkinshaw United Kingdom	9	191 1.4×	74 0.9×	19 0.8×	8 0.4×	7 0.5×	13	307

Countries citing papers authored by Fanglong Yang

Since Specialization

Citations

This map shows the geographic impact of Fanglong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglong Yang more than expected).

Fields of papers citing papers by Fanglong Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanglong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglong Yang. The network helps show where Fanglong Yang may publish in the future.

Co-authorship network of co-authors of Fanglong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Fanglong Yang. A scholar is included among the top collaborators of Fanglong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanglong Yang. Fanglong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Meng, Xin Jia, Sheng Zhao, et al.. (2025). Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency. Journal of Medicinal Chemistry. 68(6). 6766–6788.

Li, Fu, Wei Yan, Yan Li, et al.. (2025). Abstract 343: GenSci143, a novel B7-H3×PSMA bispecific and potential best-in-class ADC, for the treatment of metastatic castration-resistant prostate cancer. Cancer Research. 85(8_Supplement_1). 343–343. 1 indexed citations

Shen, Gong, Zimo Yang, Yi Lv, et al.. (2025). Development of Highly Selective Aldosterone Synthase Inhibitors. ACS Medicinal Chemistry Letters. 16(6). 1175–1181.

Yang, Zimo, Tian Han, Han Long, et al.. (2025). Discovery of a Novel p38α-MK2 Complex Inhibitor as a Potential Choice for Autoimmune Diseases. Journal of Medicinal Chemistry. 68(2). 1328–1343. 1 indexed citations

Chai, Xiaojuan, Fu Li, Yuting Lu, et al.. (2025). Abstract 340: GenSci139, a highly differentiated EGFR×HER2 bispecific ADC, for the treatment of multiple solid tumors. Cancer Research. 85(8_Supplement_1). 340–340. 1 indexed citations

Zhang, Limin, Fanglong Yang, Gang Chen, et al.. (2025). Abstract 396: Discovery of SHR3591, a highly potent and orally bioavailable AR PROTAC for the treatment of prostate cancer. Cancer Research. 85(8_Supplement_1). 396–396.

Tu, Peng, Yuanfeng Xia, Biao Lu, et al.. (2024). Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer. ACS Medicinal Chemistry Letters. 15(10). 1778–1786. 2 indexed citations

Tu, Peng, Chen Zhang, Biao Lu, Yuanfeng Xia, & Fanglong Yang. (2024). Abstract 664: GSC000190, a highly potent inhibitor of KIF18A, for tumors with chromosome instability. Cancer Research. 84(6_Supplement). 664–664. 3 indexed citations

Hu, Qiyue, Shenglan Wang, Wangyang Tu, et al.. (2021). Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors. ACS Medicinal Chemistry Letters. 12(2). 195–201. 3 indexed citations

10.

Tu, Wangyang, Fanglong Yang, Zhiwei Liu, et al.. (2019). Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors. ACS Medicinal Chemistry Letters. 10(6). 949–953. 23 indexed citations

11.

Tu, Wangyang, Zhiwei Liu, Jian Qu, et al.. (2013). Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists. Bioorganic & Medicinal Chemistry Letters. 24(1). 141–146. 12 indexed citations

12.

Yang, Fanglong, Suxin Zheng, Qiyue Hu, et al.. (2013). Discovery of novel orally bioavailable GPR40 agonists. Bioorganic & Medicinal Chemistry Letters. 23(10). 2920–2924. 12 indexed citations

13.

Yang, Fanglong, et al.. (2007). On the structure of the Phytophthora α1 mating hormone: synthesis and comparison of four candidate stereoisomers. Tetrahedron Letters. 48(45). 7965–7968. 18 indexed citations

14.

Zhu, Guangyu, Fanglong Yang, Raghavan Balachandran, et al.. (2006). Synthesis and Biological Evaluation of Purealin and Analogues as Cytoplasmic Dynein Heavy Chain Inhibitors. Journal of Medicinal Chemistry. 49(6). 2063–2076. 36 indexed citations

15.

Yang, Fanglong, et al.. (2006). Structure Assignment of Lagunapyrone B by Fluorous Mixture Synthesis of Four Candidate Stereoisomers. Journal of the American Chemical Society. 128(43). 14200–14205. 44 indexed citations

16.

Yang, Fanglong, Gang Zhao, Yu Ding, Zongbao K. Zhao, & Yue‐Qing Zheng. (2002). A new coupling reaction of propargyl carbonates mediated by Ti(O i Pr) 2 Cl 2 /Mg. Tetrahedron Letters. 43(7). 1289–1293. 24 indexed citations

17.

Curran, Dennis P., et al.. (2002). Relative Rates and Approximate Rate Constants for Inter- and Intramolecular Hydrogen Transfer Reactions of Polymer-Bound Radicals. Journal of the American Chemical Society. 124(50). 14993–15000. 18 indexed citations

18.

Yang, Fanglong, Gang Zhao, & Yu Ding. (2001). Nucleophilic reactions of propargyl acetates mediated by titanocene dichloride and magnesium. Tetrahedron Letters. 42(15). 2839–2841. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact